PT  - JOURNAL ARTICLE
AU  - Boltz, Kathy
ED  - Lophaven, Søren
TI  - Post hoc FOCUS Analysis
DP  - 2015 Sep 11
TA  - MD Conference Express
PG  - 8--9
VI  - 15
IP  - 11
4099  - http://mdc.sagepub.com/content/15/11/8.short
4100  - http://mdc.sagepub.com/content/15/11/8.full
AB  - Cognitive function in the domains of processing speed, executive functioning, and attention was statistically superior for patients with major depressive disorder who received vortioxetine 10 or 20 mg/d vs placebo. Cognitive function was assessed with the Digit Symbol Substitution Test in this post-hoc analysis of the FOCUS trial.